You are here

  • Home
  • Archive
  • Volume 12, Issue 4
  • Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial

Citation Tools

Article menu
Oncology
Protocol
Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ogasawara S, Koroki K, Makishima H, et al
Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial
BMJ Open 2022;12:e059779. doi: 10.1136/bmjopen-2021-059779